Curocell Inc. (KOSDAQ: A372320)
Health Care · Biotechnology · KR
₩26,150.00
+13.70% today · -34.5% 1Y
Curocell Inc. (KOSDAQ: A372320) operates in the Biotechnology industry within the Health Care sector. The company is valued at $296.19M.
Over the last twelve months the share price has lost 34.5%, trading between 20.65K and 66.00K.
Tweenvest scores Curocell Inc. across four factors: quality 33/100, value 45/100. Its strongest factor is value.
A372320 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $296.19M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -3,511.04
- Dividend yield
- —
- Beta (5Y)
- 0.80
- 52-week high
- ₩66,000.00
- 52-week low
- ₩20,650.00
- Avg volume (3M)
- —
- Shares outstanding
- 15.23M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Benitec Biopharma Inc.NasdaqCM: BNTC | $309.41M | $9.07 | +2.25% |
| TCM Biotech International Corp.TWSE: 4169 | $306.45M | NT$147.50 | -2.64% |
| Perspective Therapeutics, Inc.NYSEAM: CATX | $303.64M | $2.52 | -5.26% |
| AprilBio Co.,Ltd.KOSDAQ: A397030 | $297.93M | ₩14,560.00 | -14.45% |
| Clover Biopharmaceuticals, Ltd.SEHK: 2197 | $295.33M | HK$1.79 | -12.71% |
| X4 Pharmaceuticals, Inc.NasdaqCM: XFOR | $288.52M | $2.82 | -3.09% |
| CytoDyn Inc.OTCPK: CYDY | $287.21M | $0.20 | -11.89% |
| Eurobio Scientific Société anonymeENXTPA: ALERS | $284.09M | €25.30 | +0.40% |
Figures last refreshed Oct 11, 2026.